Compare · WBX vs ZBH
WBX vs ZBH
Side-by-side comparison of Wallbox N.V. (WBX) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- WBX operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $19.26B, about 275.1x WBX ($70.0M).
- ZBH has hit the wire 7 times in the past 4 weeks while WBX has been quiet.
- ZBH has more recent analyst coverage (25 ratings vs 14 for WBX).
- Company
- Wallbox N.V.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $70.0M
- $19.26B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 0
- 7
- Recent ratings
- 14
- 25
Wallbox N.V.
Wallbox N.V., a technology company, creates electric vehicle charging and energy management systems that redefine users' relationship to the grid. It provides a portfolio of charging and energy management solutions for residential, semi-public, and public use worldwide. The company was founded in 2015 and is based in Barcelona, Spain.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest WBX
- SEC Form F-1 filed by Wallbox N.V.
- SEC Form 6-K filed by Wallbox N.V.
- Wallbox Announces Second Quarter 2026 Financial Results
- Wallbox and Turning Point Energy Surpass 10,000 EV Chargers Deployed Across Saudi Arabia
- Wallbox Announces Timing of its Second Quarter 2026 Financial Results
- Wallbox Announces NYSE Acceptance of Plan to Regain Compliance with Continued Listing Standards
- SEC Form 6-K filed by Wallbox N.V.
- Director Mera Francisco Jose Riberas bought $1,364,504 worth of Class A Ordinary Shares (501,361 units at $2.72) (SEC Form 4)
- Director Aguera Pedro Alonso bought $1,364,504 worth of Class A Ordinary Shares (501,361 units at $2.72) (SEC Form 4)
- Chief Executive Officer Escorsa Enric Asuncion bought $886,929 worth of Class A Ordinary Shares (325,885 units at $2.72) (SEC Form 4)
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region